Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Systemic administration of PRO051 in Duchenne's muscular dystrophy.

Goemans NM, Tulinius M, van den Akker JT, Burm BE, Ekhart PF, Heuvelmans N, Holling T, Janson AA, Platenburg GJ, Sipkens JA, Sitsen JM, Aartsma-Rus A, van Ommen GJ, Buyse G, Darin N, Verschuuren JJ, Campion GV, de Kimpe SJ, van Deutekom JC.

N Engl J Med. 2011 Apr 21;364(16):1513-22. doi: 10.1056/NEJMoa1011367. Epub 2011 Mar 23. Erratum in: N Engl J Med. 2011 Oct 6;365(14):1361.

2.

Relapse prevention with gepirone ER in outpatients with major depression.

Keller MB, Ruwe FJ, Janssens CJ, Sitsen JM, Jokinen R, Janczewski J.

J Clin Psychopharmacol. 2005 Feb;25(1):79-84.

PMID:
15643103
4.

A review of the efficacy and tolerability of immediate-release and extended-release formulations of gepirone.

Robinson DS, Sitsen JM, Gibertini M.

Clin Ther. 2003 Jun;25(6):1618-33. Review.

PMID:
12860488
5.

Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.

Feiger AD, Heiser JF, Shrivastava RK, Weiss KJ, Smith WT, Sitsen JM, Gibertini M.

J Clin Psychiatry. 2003 Mar;64(3):243-9.

PMID:
12716264
6.

Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects.

Sennef C, Timmer CJ, Sitsen JM.

Hum Psychopharmacol. 2003 Mar;18(2):91-101.

PMID:
12590402
7.

Mirtazapine and paroxetine: a drug-drug interaction study in healthy subjects.

Ruwe FJ, Smulders RA, Kleijn HJ, Hartmans HL, Sitsen JM.

Hum Psychopharmacol. 2001 Aug;16(6):449-459.

PMID:
12404553
8.

Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects.

Spaans E, van den Heuvel MW, Schnabel PG, Peeters PA, Chin-Kon-Sung UG, Colbers EP, Sitsen JM.

Eur J Clin Pharmacol. 2002 Sep;58(6):423-9. Epub 2002 Aug 14.

PMID:
12242602
9.

Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects.

Sitsen JM, Maris FA, Timmer CJ.

Eur J Clin Pharmacol. 2000 Aug;56(5):389-94.

PMID:
11009047
10.

Pharmacokinetics of mirtazapine and lithium in healthy male subjects.

Sitsen JM, Voortman G, Timmer CJ.

J Psychopharmacol. 2000 Jun;14(2):172-6.

PMID:
10890312
11.

Clinical pharmacokinetics of mirtazapine.

Timmer CJ, Sitsen JM, Delbressine LP.

Clin Pharmacokinet. 2000 Jun;38(6):461-74. Review.

PMID:
10885584
12.

Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.

Loonen AJ, Doorschot CH, Oostelbos MC, Sitsen JM.

Eur Neuropsychopharmacol. 1999 Dec;10(1):51-7.

PMID:
10647097
14.

Differential sensitivity to morphine in spontaneously hypertensive and normotensive Wistar-Kyoto and Wistar rats.

Sitsen JM, Nijkamp FP, de Jong W.

Clin Exp Hypertens A. 1987;9(7):1159-71.

PMID:
3621633
15.

Alpha 2-adrenoceptor antagonists as antidepressants: the search for selectivity.

Pinder RM, Sitsen JM.

Psychopharmacol Ser. 1987;3:107-12. No abstract available.

PMID:
2881289
16.
17.

Buprenorphine versus domperidone in chemotherapy-induced emesis: a pilot study.

Dullemond-Westland AC, Neijt JP, Nortier JW, Sitsen JM.

Radiother Oncol. 1986 Jun;6(2):127-33.

PMID:
3526421
18.

N alpha-Acetyl-gamma-endorphin is an endogenous non-opioid neuropeptide with biological activity.

Wiegant VM, Verhoef J, Burbach JP, van Amerongen A, Gaffori O, Sitsen JM, de Wied D.

Life Sci. 1985 Jun 17;36(24):2277-85.

PMID:
2861546
19.

Chemotherapy of metastatic islet cell carcinoma. Report of 4 cases and review of the literature.

Vasen HF, Sitsen JM, Nortier JW, Lips CJ.

Neth J Med. 1985;28(4):172-5. No abstract available.

PMID:
2987713
20.

Is the hypothermic effect of alpha-methyldopa mediated by opioid peptides?

Sitsen JM, Nijkamp FP.

J Pharm Pharmacol. 1984 Jul;36(7):481-3.

PMID:
6146699

Supplemental Content

Loading ...
Support Center